Purple Biotech Ltd (PPBT) — Working Capital to Net Assets Ratio
Purple Biotech Ltd (PPBT) has a Working Capital to Net Assets ratio of 14.4% as of September 2025. Working capital of ILA4.72 Million (current assets of ILA10.77 Million minus current liabilities of ILA6.06 Million) is measured against net assets of ILA32.81 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See PPBT net asset quality score to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Purple Biotech Ltd Working Capital to Net Assets (2017–2024)
This chart shows how Purple Biotech Ltd's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the ratio stands at 14.4%, reflecting working capital of ILA4.72 Million against net assets of ILA32.81 Million ILA. Check Purple Biotech Ltd tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Purple Biotech Ltd (2017–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Purple Biotech Ltd from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see PPBT company net worth.
| Year | WC/NA Ratio | Working Capital (ILA) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 15.0% | ILA4.92 Million | ILA32.91 Million | ILA8.91 Million | ILA3.99 Million | ▼ -2.8 pp |
| 2023 | 17.7% | ILA6.09 Million | ILA34.30 Million | ILA15.79 Million | ILA9.70 Million | ▼ -37.9 pp |
| 2022 | 55.6% | ILA26.20 Million | ILA47.10 Million | ILA33.26 Million | ILA7.06 Million | ▼ -12.3 pp |
| 2021 | 67.9% | ILA44.22 Million | ILA65.11 Million | ILA48.47 Million | ILA4.25 Million | ▼ -2.5 pp |
| 2020 | 70.4% | ILA56.18 Million | ILA79.75 Million | ILA59.28 Million | ILA3.10 Million | ▲ +26.7 pp |
| 2019 | 43.8% | ILA4.76 Million | ILA10.86 Million | ILA8.30 Million | ILA3.55 Million | ▼ -3.5 pp |
| 2018 | 47.3% | ILA5.20 Million | ILA11.00 Million | ILA8.51 Million | ILA3.31 Million | ▲ +0.6 pp |
| 2017 | 46.7% | ILA4.01 Million | ILA8.59 Million | ILA7.98 Million | ILA3.97 Million | — |